e-learning
resources
Milan 2017
Tuesday, 12.09.2017
ME12 Comorbidities in lung cancer progression
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comorbidities in lung cancer progression
P. Schnabel (Homburg/Saar, Germany), N. Kahn (Heidelberg, Germany)
Source:
International Congress 2017 – ME12 Comorbidities in lung cancer progression
Session:
ME12 Comorbidities in lung cancer progression
Session type:
Meet the expert
Number:
4327
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Schnabel (Homburg/Saar, Germany), N. Kahn (Heidelberg, Germany). Comorbidities in lung cancer progression. International Congress 2017 – ME12 Comorbidities in lung cancer progression
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Bilateral lung cancer with COPD or metastatic disease
Source: International Congress 2016 – CC4 Major challenges in thoracic surgical oncology
Year: 2016
Incidence of lung cancer among COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 494s
Year: 2005
Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020
Markers of angiogenesis in serum are correlating with disease progress in lung cancer
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006
Risk factors for lung cancer in COPD
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Accompanying diseases in lung cancer patients
Source: Eur Respir J 2006; 28: Suppl. 50, 127s
Year: 2006
Aerosoltherapy in lung cancer
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008
Efficacy of osimertinib and histomolecular profile at progression in EGFR-mutated lung cancer
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019
Venothromboembolism in lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 601s
Year: 2007
Smoking and lung cancer
Source: International Congress 2018 – Effect of tobacco use on health
Year: 2018
Pecularities of lung cancer in patients with COPD
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011
Epigenetics and lung cancer
Source: Annual Congress 2006 - Epigenetics and respiratory disease
Year: 2006
Smoking status, COPD and lung cancer surgery
Source: Eur Respir J 2005; 26: Suppl. 49, 494s
Year: 2005
The burden of emphysema on lung cancer prognosis
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
Chronic obstructive pulmonary disease is an independent risk factor for nonsmall cell lung cancer in smokers
Source: Eur Respir J 2002; 20: Suppl. 38, 254s
Year: 2002
Predictors of major serious manifestations in the terminal stage of lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005
Effect of cardiovascular comorbidities on the survival patients with stage I and II non-small-cell lung cancer
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Anemia during lung cancer
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept